Patrick Lamy, Senior VP, Commercial Strategy: Akero Therapeutics AKRO Sell · Filed 24/12/18

Trade details

Type: Insider sale
Amount: $29,130
Shares · price: 1,000 sh · $29.13 a share
Held after: 34,258 sh
Stock: Akero Therapeutics AKRO
Person: Patrick LamySenior VP, Commercial Strategy
Trade date: 24/12/16
Filed: 24/12/18
Days to filing: 2 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/16~25/01/15

Patrick Lamy's recent trades

Patrick LamySenior VP, Commercial Strategy
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$105.8K
2,000 sh
$105.8K
Filed 25/07/03
Traded 25/07/01
Patrick LamySenior VP, Commercial Strategy
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$47.8K
875 sh
$47.8K
Filed 25/06/20
Traded 25/06/20
Patrick LamySenior VP, Commercial Strategy
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$80.7K
1,500 sh
$80.7K
Filed 25/06/20
Traded 25/06/16
Patrick LamySenior VP, Commercial Strategy
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$27.5K
500 sh
$27.5K
Filed 25/06/20
Traded 25/06/16
Patrick LamySenior VP, Commercial Strategy
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$49.6K
919 sh
$49.6K
Filed 25/06/12
Traded 25/06/10